AI assistant
Coloplast Director's Dealing 2021
3358_rpt_2021-05-21_0b0832dc-9d74-4155-bc80-1ee60eb83461.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Coloplast A/S Holtedam 1 3050 Humlebæk Danmark Tlf: 4911 1111 www.coloplast.com CVR-nr. 69749917
Report on transactions of executives and related parties in Coloplast shares and related securities
According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.
The below transaction concerns purchase of shares.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Gerda Loius-Hansen | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Related party to Niels Peter Louis-Hansen (deputy chairman) |
|||
| b) | Initial notification/Amendment | Initial notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
| a) | Name | Coloplast A/S (CVR-no.: 69749917) | |||
| b) | LEI | 529900NN7SOJ5QG82X67 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
| a) | B shares Description of the financial instrument, type of instrument |
||||
| Identification code | ISIN: DK0060448595 (B shares) | ||||
| b) | Nature of the transaction | Sale of shares | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| 960.40 | 123 | ||||
| 960.30 | 76 | ||||
| 960.40 | 78 | ||||
| 960.30 | 69 | ||||
| 960.40 | 66 | ||||
| 960.30 | 68 | ||||
| 960.30 | 66 | ||||
| 960.30 | 64 | ||||
| 960.30 | 66 | ||||
| 960.20 | 98 | ||||
| 960.80 | 60 |
| 960.80 | 60 |
|---|---|
| 960.80 | 6 |
| 961.00 | 23 |
| 961.00 | 44 |
| 961.00 | 7 |
| 961.00 | 7 |
| 961.00 | 44 |
| 961.00 | 55 |
| 960.40 | 78 |
| 960.70 | 74 |
| 960.80 | 19 |
| 960.80 | 1 |
| 960.80 | 22 |
| 960.40 | 79 |
| 960.40 | 65 |
| 960.40 | 57 |
| 960.40 | 88 |
| 962.00 | 51 |
| 962.00 | 143 |
| 963.20 | 44 |
| 963.80 | 144 |
| 963.00 | 64 |
| 963.20 | 35 |
| 963.20 | 23 |
| 962.40 | 5 |
| 962.40 | 3 |
| 962.40 | 3 |
| 76 | |
| 963.00 | 41 |
| 963.00 | 46 |
| 962.00 | 113 |
| 962.00 | 24 |
| 962.00 | 49 |
| 961.40 | 63 |
| 961.40 | |
| 961.40 | 76 |
| 961.20 | 60 |
| 961.20 | 6 46 |
| 961.20 | |
| 961.20 | 132 |
| 961.20 | 11 |
| 961.80 | 46 |
| 961.80 | 140 |
| 962.00 | 60 |
| 962.00 | 24 |
| 962.00 | 20 |
| 962.00 | 6 |
| 961.40 | 126 |
| 961.40 | 50 |
| 961.40 | 18 |
| 960.80 | 30 |
| 960.80 | 22 |
| 960.80 | 138 | ||
|---|---|---|---|
| 960.80 | 3 | ||
| 960.40 | 79 | ||
| 960.30 | 73 | ||
| 960.40 | 76 | ||
| 960.40 | 74 | ||
| 960.00 | 74 | ||
| 960.00 | 114 | ||
| 960.20 | 69 | ||
| 960.00 | 51 | ||
| 960.30 | 79 | ||
| 960.40 | 27 | ||
| 960.80 | 83 | ||
| 960.80 | 17 | ||
| 960.80 | 97 | ||
| 960.20 | 77 | ||
| 960.40 | 66 | ||
| 961.20 | 74 | ||
| 961.20 | 20 | ||
| 961.60 | 53 | ||
| 961.60 | 121 | ||
| 961.60 | 37 | ||
| 961.80 | 36 | ||
| 963.80 | 121 | ||
| 963.80 | 3 | ||
| 963.40 | 60 | ||
| 963.40 | 23 | ||
| 963.40 | 26 | ||
| 962.60 | 66 | ||
| Aggregated information | |||
| d) | - Aggregated volume |
5,200 shares DKK 961.23 (volume weighted average) |
|
| - Price |
|||
| e) | Date of the transaction | 2021-05-19, 14:32 UTC (last trade) | |
| f) | Place of the transaction | Nasdaq Copenhagen A/S (XCSE) |
This information is available in Danish and in English, in case of doubt the Danish version prevails. For further information: Hannah Katrine Larsen, tel.: +45 4911 3616.
Our mission
Making life easier for people with intimate health care needs
Our values
Closeness... to better understand Passion... to make a difference Respect and responsibility... to guide us
Our vision
Setting the global standard for listening and responding
For further information, please contact
Investors and analysts Press and media Address
Anders Lonning-Skovgaard Executive Vice President, CFO Tel. +45 4911 1111
Ellen Bjurgert Vice President, Investor Relations Tel. +45 4911 1800 /+45 4911 3376 Email: [email protected]
Aleksandra Dimovska Sr. Manager, Investor Relations Tel. +45 4911 1800 /+45 4911 2458 Email: [email protected]
Peter Mønster Sr. Media Relations Manager Tel. +45 4911 2623 Email: [email protected]
Coloplast A/S Holtedam 1 DK-3050 Humlebaek Denmark Company reg. (CVR) no. 69749917
Website
www.coloplast.com
This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.
Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,500 employees.
The Coloplast logo is a registered trademark of Coloplast A/S. © 2021-05. All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.